MiMedx Group, Inc. develops, processes, and markets patent protected and proprietary regenerative biomaterial products and bioimplants processed from human amniotic membrane and other birth tissues, and human skin and bone. The company processes the human amniotic membrane utilizing its proprietary PURION Process to produce an implant. It also supplies amniotic tissue comprising approximately 500,000 allografts for applications in the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare.
Take a look at the 1-year chart of MiMedx (Nasdaq: MDXG) with the added notations:
After finishing its June to October drop, MDXG has bounced off the $7 support (green) on a couple of occasions. The stock appears to be falling back down to that support level again; traders should be able to expect some sort of bounce. However, if the $7 support were to break, lower prices should follow.
Join our new Linkedin Group by clicking the link below:
The Tale of the Tape: MDXG has a key level of support at $7. A trader could enter a long position at $7 with a stop placed under the level. If the stock were to break below the support a short position could be entered instead.
Before making any trading decision, decide which side of the trade you believe gives you the highest probability of success. Do you prefer the short side of the market, long side, or do you want to be in the market at all? If you haven’t thought about it, review the overall indices themselves. For example, take a look at the S&P 500. Is it trending higher or lower? Has it recently broken through a key resistance or support level? Making these decisions ahead of time will help you decide which side of the trade you believe gives you the best opportunities.
No matter what your strategy or when you decide to enter, always remember to use protective stops and you’ll be around for the next trade. Capital preservation is always key!
Christian Tharp, CMT
Follow me on Twitter: @cmtstockcoach